Chudnovsky Yekaterina

Chudnovsky Yekaterina is listed in filings as Director at Immix Biopharma, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including purchase activity. Recent filings connect the profile to Immix Biopharma, Inc. (IMMX) and Elicio Therapeutics, Inc. (ELTX). The current snapshot covers public activity from Jun 21, 2024 to May 29, 2026. Reported amounts are shown as $109.8K to $800.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.